Pacira BioSciences, Inc. (PCRX)

Pharmaceutical Preparations

Latest Price

$36.40

TTM P/E

101.11

Normalized P/E

TTM Div Yield

Fwd Div Yield

Book Value

17.08

P/B Ratio

2.13

Valuation metrics

EPS: $0.16

Book value / share: $16.86

Formula: √(22.5 × EPS × BVPS)

Graham Number

$7.79

79% downside

Norm. op. income: $46M (median of 7yr)

Tax rate: 32%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$4.41

88% downside

Base FCF: $137M (median of recent 5yr)

Growth: 23%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$211.51

+481% upside

EPS: $0.16

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$2.40

93% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	6.71M	$170.0M	16.84%	-29.5K	2026-06-30
Doma Perpetual Capital Management LLC	2.78M	$70.0M	6.98%	--	2026-06-30
Vanguard Portfolio Management LLC	2.41M	$61.0M	6.04%	-95.0K	2026-06-30
Dimensional Fund Advisors LP	2.10M	$53.0M	5.28%	+42.6K	2026-06-30
State Street Corp	2.06M	$52.0M	5.17%	+140.4K	2026-06-30
D. E. Shaw & Co., Inc.	1.95M	$49.0M	4.90%	-32.4K	2026-06-30
Renaissance Technologies LLC	1.73M	$43.0M	4.35%	-91.7K	2026-06-30
Vanguard Capital Management LLC	1.69M	$42.0M	4.25%	-92.5K	2026-06-30
Goldman Sachs Group Inc	1.53M	$38.0M	3.83%	-42.8K	2026-06-30
Geode Capital Management, LLC	1.16M	$29.0M	2.91%	+14.9K	2026-06-30